Collectively, all these data suggest that upregulation of miR-101 in the calcified human aortic valves may play an important role in promoting CAVD development via targeting the protein expression of CDH11 and SOX9. The gene discussed is CDH11; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.